Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 13, 2018 - Issue
Submit an article Journal homepage
75
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Characteristics of 2017 GOLD COPD group A: a multicenter cross-sectional CAP study in Japan

Keiji Oishi1 Department of Medicine and Clinical Science, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan, [email protected]Correspondence[email protected]
,
Tsunahiko Hirano2 Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan
,
Kazuki Hamada2 Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan
,
Sho Uehara2 Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan
,
Ryo Suetake2 Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan
,
Yoshikazu Yamaji2 Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan
,
Kosuke Ito2 Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan
,
Maki Asami-Noyama2 Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan
,
Nobutaka Edakuni2 Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan
&
Kazuto Matsunaga2 Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan
 show all
Pages 3901-3907 | Published online: 05 Dec 2018

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Alexandrosz Czira, Sneha Purushotham, Ike Iheanacho, Kieran J Rothnie, Chris Compton & Afisi S Ismaila. (2023) Burden of Disease in Patients with Mild or Mild-to-Moderate Chronic Obstructive Pulmonary Disease (Global Initiative for Chronic Obstructive Lung Disease Group A or B): A Systematic Literature Review. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 719-731.
Read now
Yi Zhang, Naoya Tanabe, Hiroshi Shima, Yusuke Shiraisi, Tsuyoshi Oguma, Atsuyasu Sato, Shigeo Muro, Susumu Sato & Toyohiro Hirai. (2022) Physiological Impairments on Respiratory Oscillometry and Future Exacerbations in Chronic Obstructive Pulmonary Disease Patients without a History of Frequent Exacerbations. COPD: Journal of Chronic Obstructive Pulmonary Disease 19:1, pages 149-157.
Read now
Qing Song, Yi-Yang Zhao, Yu-Qin Zeng, Cong Liu, Wei Cheng, Min-Hua Deng, Xin Li, Li-Bing Ma, Yan Chen, Shan Cai & Ping Chen. (2021) The Characteristics of Airflow Limitation and Future Exacerbations in Different GOLD Groups of COPD Patients. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1401-1412.
Read now

Articles from other publishers (7)

Ting Yang, Baiqiang Cai, Bin Cao, Jian Kang, Fuqiang Wen, Yahong Chen, Wenhua Jian, Hongyan Shang & Chen Wang. (2022) Severity distribution and treatment of chronic obstructive pulmonary disease in China: baseline results of an observational study. Respiratory Research 23:1.
Crossref
Sun Hye Shin, Deog Kyeom Kim, Sang-Heon Kim, Tae Rim Shin, Ki-Suck Jung, Kwang Ha Yoo, Ki-Eun Hwang, Hye Yun Park & Yong Suk Jo. (2022) Lack of Association between Inhaled Corticosteroid Use and the Risk of Future Exacerbation in Patients with GOLD Group A Chronic Obstructive Pulmonary Disease. Journal of Personalized Medicine 12:6, pages 916.
Crossref
Tomoko Taniguchi, Dong Wang, Hajime Yoshisue, Makoto Nagasaki & Takayoshi Sasajima. (2021) Real-world Safety and Efficacy of Indacaterol Maleate in Patients with Chronic Obstructive Pulmonary Disease: Evidence from the Long-term Post-marketing Surveillance in Japan. Internal Medicine 60:15, pages 2385-2394.
Crossref
Keiji Oishi, Kazuto Matsunaga, Misa Harada, Junki Suizu, Keita Murakawa, Ayumi Chikumoto, Yuichi Ohteru, Kazuki Matsuda, Sho Uehara, Kazuki Hamada, Shuichiro Ohata, Yoriyuki Murata, Yoshikazu Yamaji, Maki Asami-Noyama, Nobutaka Edakuni, Tomoyuki Kakugawa & Tsunahiko Hirano. (2020) A New Dyspnea Evaluation System Focusing on Patients’ Perceptions of Dyspnea and Their Living Disabilities: The Linkage between COPD and Frailty. Journal of Clinical Medicine 9:11, pages 3580.
Crossref
Kazuto Matsunaga, Misa Harada, Junki Suizu, Keiji Oishi, Maki Asami-Noyama & Tsunahiko Hirano. (2020) Comorbid Conditions in Chronic Obstructive Pulmonary Disease: Potential Therapeutic Targets for Unmet Needs. Journal of Clinical Medicine 9:10, pages 3078.
Crossref
Keiji Oishi, Kazuto Matsunaga, Toshihiro Shirai, Keita Hirai & Yasuhiro Gon. (2020) Role of Type2 Inflammatory Biomarkers in Chronic Obstructive Pulmonary Disease. Journal of Clinical Medicine 9:8, pages 2670.
Crossref
Yoshikazu Yamaji, Keiji Oishi, Kazuki Hamada, Yuichi Ohteru, Ayumi Chikumoto, Keita Murakawa, Kazuki Matsuda, Ryo Suetake, Yoriyuki Murata, Kosuke Ito, Maki Asami-Noyama, Nobutaka Edakuni, Tsunahiko Hirano & Kazuto Matsunaga. (2020) Detection of type2 biomarkers for response in COPD. Journal of Breath Research 14:2, pages 026007.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.